Nuclear Organization of RNA Polymerase III Transcription

RNA 聚合酶 III 转录的核组织

基本信息

  • 批准号:
    7643817
  • 负责人:
  • 金额:
    $ 29.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Genetic information is usually represented as linear arrays on chromosomes, yet nuclear DNA exists in a highly compacted form in which access to individual genes must be considered as a three-dimensional problem. Cytological evidence for a limited number of loci in several eukaryotes has suggested that localization of at least some genes is related to the transcriptional activity of the genes, and that this positioning can change in response to metabolic and developmental signals. Using the budding yeast, Saccharomyces cerevisiae, we have recently shown that the 275 tRNA genes, although widely scattered in the linear genome, are gathered near the nucleolus throughout the cell cycle. This clustering of the tRNA genes, while potentially advantageous in terms of RNA polymerase III (pol III) transcriptional regulation and an ordered pre-Trna processing pathway, has striking implications for spatial organization of much of the yeast genome. The clustering is pol III transcription-dependent, and affects both recombinations between tRNA genes and nearby transcription by RNA polymerase II. In preliminary studies we have now shown that nucleolar tRNA gene localization is a two step process, with condensin-dependent clustering of the tRNA genes separable from microtubule-dependent localization of the clusters to the nucleolus. The near-term goal of this project is to characterize the mechanisms of this large-scale organization of the individual tRNA genes in yeast, to take advantage of the molecular genetic tools. In the longer term we will also investigate whether this phenomenon affects the behavior of RNA polymerase III transcription units in mammals. Genomes from humans and other vertebrates contain not only hundreds of tRNA genes, but hundreds of thousands of short interspersed DNA elements (SINEs) with tRNA-class promoters. Some of these short interspersed DNA elements (SINEs) are known to influence both nearby transcription by RNA polymerase II and recombination events that are associated with developmental abnormalities and cancers. We anticipate that understanding the spatial behavior of pol III transcription units could provide broad insights into constraints on genome organization and regulation. PUBLIC HEALTH RELEVANCE: DNA in living cells is extremely condensed and packaged in a highly organized fashion. This packaging facilitates regulated retrieval of genetic information and affects DNA recombination events that can lead to cancers and developmental abnormalities. We have identified a type of abundant DNA element, distributed throughout genomes of higher cells, that both encodes small RNAs and serves as a three-dimensional organization signal. We are investigating the molecular mechanisms of this organization and the nature of the resulting DNA packaging.
描述(由申请人提供):遗传信息通常以染色体上的线性阵列表示,但核DNA以高度紧凑的形式存在,其中对单个基因的访问必须被视为三维问题。在几种真核生物中有限数量的基因座的细胞学证据表明,至少一些基因的定位与基因的转录活性有关,并且这种定位可以响应代谢和发育信号而改变。利用出芽酵母(Saccharomyces cerevisiae),我们最近发现275个tRNA基因虽然广泛分布在线性基因组中,但在整个细胞周期中都聚集在核核附近。tRNA基因的这种聚类,虽然在RNA聚合酶III (pol III)转录调控和有序的tRNA前加工途径方面具有潜在的优势,但对酵母基因组的空间组织具有显著的意义。聚类是pol III转录依赖的,影响tRNA基因之间的重组和附近RNA聚合酶II的转录。在初步的研究中,我们现在已经表明核仁tRNA基因定位是一个两步的过程,tRNA基因的凝聚依赖的集群可与微管依赖的集群定位到核仁分开。该项目的近期目标是利用分子遗传学工具,表征酵母中单个tRNA基因的大规模组织机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID R ENGELKE其他文献

DAVID R ENGELKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID R ENGELKE', 18)}}的其他基金

RNASE P
核糖核酸酶P
  • 批准号:
    8365869
  • 财政年份:
    2011
  • 资助金额:
    $ 29.96万
  • 项目类别:
RNASE P
核糖核酸酶P
  • 批准号:
    8171431
  • 财政年份:
    2010
  • 资助金额:
    $ 29.96万
  • 项目类别:
TAP TAG PULL DOWN OF NOVEL PROTEINS INVOLVED IN TGM SILENCING
TAP 标签下拉参与 TGM 沉默的新型蛋白质
  • 批准号:
    8171430
  • 财政年份:
    2010
  • 资助金额:
    $ 29.96万
  • 项目类别:
Nuclear Organization of RNA Polymerase III Transcription
RNA 聚合酶 III 转录的核组织
  • 批准号:
    7883878
  • 财政年份:
    2009
  • 资助金额:
    $ 29.96万
  • 项目类别:
Nuclear Organization of RNA Polymerase III Transcription
RNA 聚合酶 III 转录的核组织
  • 批准号:
    7525019
  • 财政年份:
    2008
  • 资助金额:
    $ 29.96万
  • 项目类别:
Nuclear Organization of RNA Polymerase III Transcription
RNA 聚合酶 III 转录的核组织
  • 批准号:
    8063228
  • 财政年份:
    2008
  • 资助金额:
    $ 29.96万
  • 项目类别:
RNASE P
核糖核酸酶P
  • 批准号:
    7723627
  • 财政年份:
    2008
  • 资助金额:
    $ 29.96万
  • 项目类别:
Nuclear Organization of RNA Polymerase III Transcription
RNA 聚合酶 III 转录的核组织
  • 批准号:
    7826939
  • 财政年份:
    2008
  • 资助金额:
    $ 29.96万
  • 项目类别:
TAP TAG PULL DOWN OF NOVEL PROTEINS INVOLVED IN TGM SILENCING
TAP 标签下拉参与 TGM 沉默的新型蛋白质
  • 批准号:
    7420796
  • 财政年份:
    2006
  • 资助金额:
    $ 29.96万
  • 项目类别:
RNASE P
核糖核酸酶P
  • 批准号:
    7420820
  • 财政年份:
    2006
  • 资助金额:
    $ 29.96万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 29.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 29.96万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了